Fundraising FoxAvenge Bio
5 known investors
Find your way into Avenge Bio
Sign up to see every warm intro you have to Avenge Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Avenge Bio team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biotechnology company developing the LOCOcyte cell-therapy platform for local dosing of immunotherapeutics.
Investors · 5
Longitude Capitallisted by Longitude CapitalMenlo Park · $10M – $30M
How we know: Longitude Capital's portfolio page · funding news · pulse2.com · the VCSheet dataset · Not right? Tell us
Pappas CapitalreportedResearch Triangle Park · $100K – $6M
How we know: pulse2.com · Not right? Tell us
Rock Springs CapitalreportedBaltimore
How we know: funding news · pulse2.com · Not right? Tell us
Also in the syndicate · 1
CAM Capitallead
Funding
SEC filings, press & company announcements- Undisclosed amountSeries AJan 2022
CAM Capital (lead), Perceptive Xontogeny Venture Fund (lead), Longitude Capital, Pappas Capital, Rock Springs Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Avenge Bio do?
- Biotechnology company developing the LOCOcyte cell-therapy platform for local dosing of immunotherapeutics.
- Who are Avenge Bio's investors?
- Avenge Bio's investors include Longitude Capital, Pappas Capital, Perceptive Xontogeny Venture, Rock Springs Capital.